Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01954251
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:56.347657+00:00
Published At
2016-02-10T00:00:00+00:00
Record Updated At
2018-05-02
Results Posted At
2016-02-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Herpes Zoster"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-05-02"
protocolSection.identificationModule.nctId
"NCT01954251"
protocolSection.identificationModule.officialTitle
"Immunogenicity and Safety Study of GSK Biologicals\u0027 Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals\u0027 Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2016-02-10"

Study condition terms

  • Herpes Zoster (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.